Serious adverse events · people with probable or definite amyotrophic lateral sclerosis/motor neuron disease (treated with riluzole)
BM‐MSC showed no clear difference in serious adverse events compared with no treatment (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (>6 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (>12 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ not reported · patients with lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Proportion with adverse events · lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Adults with lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Adults with lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · Adults with lateral elbow pain
1 finding from 1 review
Withdrawals due to adverse events · lateral elbow pain
It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events  compared with placebo at 3 months' follow‐up (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Adverse events, reported as "negative experiences" · sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis
It is very uncertain whether radiotherapy changes adverse events, reported as "negative experiences" compared with botulinum toxin (very low certainty).
1 finding from 1 review
Adverse effects: perioperative complications (number of events)
Minimally invasive parathyroidectomy may leads to lower total incidence of perioperative adverse events (number) compared with bilateral neck exploration (low certainty).
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Adverse events · people with ALS/MND
1 finding from 1 review
Intervention not reported
Adverse events · people with ALS/MND
1 finding from 1 review
Serious adverse events · patients with varus medial osteoarthritis of the knee
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (pain and swelling at injection site and limitation of elbow movement following injection) · lateral elbow pain
Autologous blood or PRP showed no clear difference in adverse events (pain and swelling at injection site and limitation… compared with placebo at 3 months' follow‐up (low certainty).
1 finding from 1 review